Dr. Julie Gerberding was director of the CDC throughout the 2003 SARS outbreak and classes discovered from that response at the moment are informing her work overseeing some 65,000 staff round the world as government vp of Merck. Gerberding talks with Dr. Josh Sharfstein about the US’s response, how Merck is maintaining issues transferring, why rising infectious illnesses could also be a brand new regular, and how the pandemic is contributing to the risk of antimicrobial resistance.
source